Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Netherlands Cancer R. Dutch Cancer Figures. 2013
van der Pool AE, Damhuis RA, Ijzermans JN et al (2012) Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14:56–61
Elferink MA, van Steenbergen LN, Krijnen P et al (2010) Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006. Eur J Cancer 46:1421–1429 (Oxford, England : 1990)
van Steenbergen LN, Elferink MA, Krijnen P et al (2010) Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006. Ann Oncol 21:2206–2212
Kanas GP, Taylor A, Primrose JN et al (2012) Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301
Hackl C, Gerken M, Loss M et al (2011) A population-based analysis on the rate and surgical management of colorectal liver metastases in southern Germany. Int J Colorectal Dis 26:1475–1481
Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683
Gonzalez M, Poncet A, Combescure C et al (2013) Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 20:572–579
de Cuba EM, Kwakman R, Knol DL et al (2013) Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321–327
de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947
Saltz LB, Cox JV, Blanke C et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905–914
Koopman M, Antonini NF, Douma J et al (2007) Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 370:135–142
Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342
Cirocchi R, Trastulli S, Abraha I et al (2012) Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. The Cochrane database of systematic reviews 8:CD008997
Verhoef C, de Wilt JH, Burger JW et al (2011) Surgery of the primary in stage IV colorectal cancer with unresectable metastases. Eur J Cancer 47(Suppl 3):S61–S66 (Oxford, England : 1990)
Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology (ICD-O). World Health Organization, Geneva
Wittekind C, Greene FL, Hutter RVP et al (2004) TNM atlas. Springer, Berlin
Nagtegaal ID, Tot T, Jayne DG et al (2011) Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol 29:2487–2492
Parnaby CN, Bailey W, Balasingam A et al (2012) Pulmonary staging in colorectal cancer: a review. Colorectal Dis 14:660–670
Bipat S, Niekel MC, Comans EF et al (2012) Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 70:26–34
Mitry E, Guiu B, Cosconea S et al (2010) Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 59:1383–1388
Wiering B, Vogel WV, Ruers TJ et al (2008) Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Dig Surg 25:413–420
Mitry E, Rollot F, Jooste V et al (2013) Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies? Eur J Cancer 49:2919–2925 (Oxford, England : 1990)
Damjanov N, Weiss J, Haller DG (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14:963–969
Benoist S, Pautrat K, Mitry E et al (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92:1155–1160
Hu CY, Bailey CE, You YN et al (2015) Time trend analysis of primary tumor resection for stage iv colorectal cancer: less surgery, improved survival. JAMA Surg 150:245–251
Scheer MG, Sloots CE, van der Wilt GJ et al (2008) Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19:1829–1835
Vargas GM, Sheffield KM, Parmar AD et al (2014) Trends in treatment and survival in older patients presenting with stage IV colorectal cancer. J Gastrointest Surg 18:369–377
Jones RP, Vauthey JN, Adam R et al (2012) Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg 99:1263–1269
Hattori N, Kanemitsu Y, Komori K et al (2013) Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg 37:1315–1321
Chua TC, Saxena A, Liauw W et al (2012) Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases–a systematic review. Eur J Cancer 48:1757–1765 (Oxford, England : 1990)
Sorbye H, Cvancarova M, Qvortrup C et al (2013) Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer. Ann Oncol 24:2354–2360
Kornmann M, Staib L, Wiegel T et al (2013) Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer. Clin Colorectal Cancer 12:54–61
Khattak MA, Martin HL, Beeke C et al (2012) Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer 11:247–254
Lemmens VE, Klaver YL, Verwaal VJ et al (2011) Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer 128:2717–2725
Mol L, Koopman M, van Gils CW et al (2013) Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Acta Oncol 52:950–955